Dr. Mark Moglowsky, MD

Gastroenterology Huntsville, AL Male
NPI: 1679527485
Total Payments
$12,186
2024 Payments
$16.51
Companies
36
Transactions
815
Medicare Patients
4,119
Medicare Billing
$428,900

Payment Breakdown by Category

Food & Beverage$12,129 (99.5%)
Education$56.99 (0.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $12,129 814 99.5%
Education $56.99 1 0.5%

Top Paying Companies

Company Total Records Latest Year
Salix Pharmaceuticals, a division of Bausch Health US, LLC $2,992 217 $0 (2023)
ABBVIE INC. $2,271 136 $0 (2023)
Janssen Biotech, Inc. $1,734 116 $0 (2023)
Takeda Pharmaceuticals U.S.A., Inc. $710.25 46 $0 (2023)
Valeant Pharmaceuticals North America LLC $629.25 35 $0 (2017)
Allergan, Inc. $528.48 50 $0 (2020)
Merck Sharp & Dohme LLC $337.70 21 $0 (2023)
QOL Medical, LLC $314.83 19 $0 (2023)
Ironwood Pharmaceuticals, Inc $309.96 19 $0 (2023)
INTERCEPT PHARMACEUTICALS, INC. $291.93 19 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $16.51 1 Micro-tech Endoscopy USA, Inc. ($16.51)
2023 $1,758 102 ABBVIE INC. ($622.03)
2022 $2,040 128 ABBVIE INC. ($547.69)
2021 $1,738 125 Janssen Biotech, Inc. ($385.39)
2020 $783.63 57 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($276.63)
2019 $2,018 145 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($866.87)
2018 $2,234 155 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($833.48)
2017 $1,597 102 Valeant Pharmaceuticals North America LLC ($629.25)

All Payment Transactions

815 individual payment records from CMS Open Payments — Page 1 of 33

Date Company Product Nature Form Amount Type
04/15/2024 Micro-tech Endoscopy USA, Inc. eyeMAX (Device) Food and Beverage In-kind items and services $16.51 General
Category: GI Endoscopy
12/27/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.76 General
Category: Gastroenterology
12/27/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.69 General
Category: Gastroenterology
12/20/2023 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $19.48 General
Category: Immunology
12/18/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.91 General
Category: Gastroenterology
12/18/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.61 General
Category: Gastroenterology
12/18/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.16 General
Category: Gastroenterology
12/04/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug) Food and Beverage In-kind items and services $12.96 General
Category: Gastroenterology
11/27/2023 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $24.99 General
Category: Immunology
11/16/2023 Ironwood Pharmaceuticals, Inc Linzess (Drug) Food and Beverage Cash or cash equivalent $17.18 General
Category: GI
11/15/2023 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $22.97 General
Category: IMMUNOLOGY
11/13/2023 ABBVIE INC. VIBERZI (Drug), LINZESS Food and Beverage In-kind items and services $5.00 General
Category: GASTROENTEROLOGY
11/08/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), PLENVU Food and Beverage In-kind items and services $14.69 General
Category: Gastroenterology
11/01/2023 Merck Sharp & Dohme LLC DIFICID (Drug) Food and Beverage In-kind items and services $17.59 General
Category: INFECTIOUS DISEASE
10/26/2023 ABBVIE INC. VIBERZI (Drug), LINZESS Food and Beverage In-kind items and services $11.08 General
Category: GASTROENTEROLOGY
10/24/2023 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $20.79 General
Category: Immunology
10/17/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), PLENVU Food and Beverage In-kind items and services $13.38 General
Category: Gastroenterology
10/16/2023 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $26.87 General
Category: IMMUNOLOGY
10/16/2023 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $25.43 General
Category: IMMUNOLOGY
10/13/2023 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $25.61 General
Category: Immunology
10/12/2023 Evoke Pharma, Inc. GIMOTI (Drug) Food and Beverage In-kind items and services $19.09 General
Category: Gastroenterology
10/11/2023 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $29.92 General
Category: IMMUNOLOGY
10/11/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.62 General
Category: Gastroenterology
10/11/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.18 General
Category: Gastroenterology
10/02/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug) Food and Beverage In-kind items and services $9.07 General
Category: Gastroenterology
123…33»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 20 868 2,308 $385,031 $92,790
2022 19 1,044 2,050 $431,176 $108,548
2021 16 1,133 2,886 $430,074 $122,321
2020 19 1,074 2,805 $377,832 $105,242
Total Patients
4,119
Total Services
10,049
Medicare Billing
$428,900
Procedure Codes
74

All Medicare Procedures & Services

74 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45388 Destruction of polyp or growth of large bowel using a flexible endoscope Facility 2023 81 81 $73,386 $16,465 22.4%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 106 106 $88,404 $13,464 15.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 87 87 $16,878 $9,002 53.3%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 52 52 $31,200 $8,810 28.2%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 134 139 $58,102 $8,414 14.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 71 73 $9,271 $5,632 60.7%
43249 Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm Facility 2023 50 56 $25,536 $5,249 20.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 72 77 $7,315 $4,724 64.6%
74177 Ct scan of abdomen and pelvis with contrast Office 2023 16 16 $7,008 $3,529 50.4%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 44 44 $5,588 $2,994 53.6%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 23 23 $5,612 $2,993 53.3%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 18 18 $10,548 $2,440 23.1%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2023 12 12 $7,200 $2,036 28.3%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 17 33 $2,871 $1,958 68.2%
43262 Incision of pancreatic outlet using a flexible endoscope Facility 2023 12 12 $13,764 $1,727 12.5%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 22 22 $15,626 $1,530 9.8%
76700 Complete ultrasound scan of abdomen Office 2023 11 12 $2,100 $966.83 46.0%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 12 12 $612.00 $479.76 78.4%
74328 Review by radiologist of image from tube placement into bile duct using an endoscope Facility 2023 11 12 $3,228 $207.84 6.4%
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Office 2023 17 1,421 $781.55 $169.11 21.6%
45388 Destruction of polyp or growth of large bowel using a flexible endoscope Facility 2022 106 107 $96,942 $21,907 22.6%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 124 126 $105,084 $14,912 14.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 162 180 $22,833 $14,847 65.0%
43249 Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm Facility 2022 69 84 $38,304 $8,891 23.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 73 73 $14,162 $7,830 55.3%
123»

About Dr. Mark Moglowsky, MD

Dr. Mark Moglowsky, MD is a Gastroenterology healthcare provider based in Huntsville, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679527485.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Moglowsky, MD has received a total of $12,186 in payments from pharmaceutical and medical device companies, with $16.51 received in 2024. These payments were reported across 815 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($12,129).

As a Medicare-enrolled provider, Moglowsky has provided services to 4,119 Medicare beneficiaries, totaling 10,049 services with total Medicare billing of $428,900. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Other Specialties Gastroenterology, Gastroenterology
  • Location Huntsville, AL
  • Active Since 05/19/2006
  • Last Updated 04/10/2018
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1679527485

Products in Payments

  • XIFAXAN (Drug) $2,099
  • STELARA (Biological) $1,734
  • LINZESS (Drug) $708.05
  • APRISO (Drug) $464.15
  • SKYRIZI (Biological) $432.59
  • TRULANCE (Drug) $370.93
  • HUMIRA (Biological) $351.52
  • DIFICID (Drug) $326.70
  • OCALIVA (Drug) $291.93
  • ZENPEP (Drug) $277.51
  • Linzess (Drug) $263.84
  • Humira (Biological) $258.35
  • RINVOQ (Biological) $251.37
  • VIBERZI (Drug) $242.19
  • ENTYVIO (Biological) $223.57
  • Entyvio (Biological) $220.01
  • DUPIXENT (Biological) $205.74
  • PLENVU (Drug) $196.75
  • CLENPIQ (Drug) $179.36
  • Sucraid (Drug) $172.98

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Huntsville

Michael Dohrenwend, Md, MD

Gastroenterology — Payments: $48,133

Gastroenterology $48,133

John-Paul Voelkel, M.d, M.D

Gastroenterology — Payments: $17,351

Gastroenterology $17,351

Meredith Roath, M.d, M.D

Gastroenterology — Payments: $16,777

Gastroenterology $16,777

Charles Billings, Md, MD

Gastroenterology — Payments: $16,031

Gastroenterology $16,031

Dino Ferrante, Md, MD

Gastroenterology — Payments: $15,843

Gastroenterology $15,843

Suresh Karne, Md Phd, MD PHD

Gastroenterology — Payments: $11,520

Gastroenterology $11,520